DLAT

Chr 11AR

dihydrolipoamide S-acetyltransferase

Also known as: DLTA, E2, PBC, PDC-E2, PDCE2

This gene encodes component E2 of the multi-enzyme pyruvate dehydrogenase complex (PDC). PDC resides in the inner mitochondrial membrane and catalyzes the conversion of pyruvate to acetyl coenzyme A. The protein product of this gene, dihydrolipoamide acetyltransferase, accepts acetyl groups formed by the oxidative decarboxylation of pyruvate and transfers them to coenzyme A. Dihydrolipoamide acetyltransferase is the antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC enventually leads to cirrhosis and liver failure. Mutations in this gene are also a cause of pyruvate dehydrogenase E2 deficiency which causes primary lactic acidosis in infancy and early childhood.[provided by RefSeq, Oct 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.861 OMIM phenotype
Clinical SummaryDLAT
🧬
Gene-Disease Validity (ClinGen)
Leigh syndrome · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
18 unique Pathogenic / Likely Pathogenic· 170 VUS of 405 total submissions
📖
GeneReview available — DLAT
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.86LOEUF
pLI 0.000
Z-score 2.14
OE 0.58 (0.390.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.42Z-score
OE missense 0.94 (0.861.03)
338 obs / 360.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.58 (0.390.86)
00.351.4
Missense OE?0.94 (0.861.03)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 17 / 29.6Missense obs/exp: 338 / 360.3Syn Z: 0.23
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveDLAT-related pyruvate dehydrogenase E2 deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6840th %ile
GOF
0.5954th %ile
LOF
0.3940th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

405 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic11
VUS170
Likely Benign144
Benign47
Conflicting13
7
Pathogenic
11
Likely Pathogenic
170
VUS
144
Likely Benign
47
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
6
0
1
0
7
Likely Pathogenic
8
2
0
1
11
VUS
3
155
10
2
170
Likely Benign
2
21
71
50
144
Benign
0
7
39
1
47
Conflicting
13
Total1918512154392

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

18 pathogenic / likely-pathogenic (of 26) ClinVar copy-number / structural variants overlap DLAT — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DLAT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →